Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor

Molecular Endocrinology

Volumn 24, Issue 5, 2010, Pages 941-952

  Kino, Tomoshige ^a   Jaffe, Howard ^b   Amin, Niranjana D ^c   Chakrabarti, Mayukh ^a   Zheng, Ya Li ^c   Chrousos, George P ^d   Pant, Harish C ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CYCLIN DEPENDENT KINASE 5; DEXAMETHASONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EMOTION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT;

ALDOSTERONE; ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TUMOR; CELLS, CULTURED; CORTICOSTERONE; CYCLIN-DEPENDENT KINASE 5; DEXAMETHASONE; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PURINES; RATS; RECEPTORS, MINERALOCORTICOID; TWO-HYBRID SYSTEM TECHNIQUES;

RATTUS;

EID: 77954874273     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0395     Document Type: Article

References (61)

1. Kino T, Chrousos GP 2005 Glucocorticoid effect on gene expression. In: Steckler T, Kalin NH, Reul JMHM, eds. Handbook on stress and the brain. Amsterdam: Elsevier BV; 295-312
2. de Kloet ER, Derijk RH, Meijer OC 2007 Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nat Clin Pract Endocrinol Metab 3:168-179
3. Fietta P, Fietta P 2007 Glucocorticoids and brain functions. Riv Biol 100:403-418
4. Rashid S, Lewis GF 2005 The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues. Clin Biochem 38:401-409 (Pubitemid 40501522)
5. Kino T, Chrousos GP 2004 Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem 40:137-155
6. Chrousos GP, Kino T 2005 Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005:pe48
7. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
8. Rosenfeld MG, Lunyak VV, Glass CK 2006 Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428
9. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E 2010 The glucocorticoid receptor: molecular basis of biologic function. Steroids 75:1-12
10. Ortlund EA, Bridgham JT, Redinbo MR, Thornton JW 2007 Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317:1544-1548
11. Chrousos GP 2001 Glucocorticoid therapy. In: Felig P, Frohman LA, eds. Endocrinology, metabolism, 4th ed. New York: McGraw-Hill; 609-632
12. Kovacs WJ, Orth DN 1998 The adrenal cortex. In: Wilson J, D, Foster DW, eds. Williams textbook of endocrinology. Philadelphia: W.B. Saunders Co.; 517-750
13. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB 1996 Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173-11178
14. Dhavan R, Tsai LH 2001 Adecade of CDK5. Nat Rev Mol Cell Biol 2:749-759
15. Tsai LH, Delalle I, Caviness Jr VS, Chae T, Harlow E 1994 p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423
16. Tang D, Wang JH 1996 Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators. Prog Cell Cycle Res 2:205-216
17. Julien JP, Mushynski WE 1998 Neurofilaments in health and disease. Prog Nucleic Acid Res Mol Biol 61:1-23
18. Lau LF, Seymour PA, Sanner MA, Schachter JB 2002 Cdk5 as a drug target for the treatment of Alzheimer's disease. J Mol Neurosci 19:267-273 (Pubitemid 36051517)
19. Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN 1999 Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34:21-29
20. Ahlijanian MK, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, McCarthy S, Coskran T, Carlo A, Seymour PA, Burkhardt JE, Nelson RB, McNeish JD 2000 Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97:2910-2915
21. Nguyen MD, Larivière RC, Julien JP 2001 Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30:135-147
22. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH 2003 Aberrant Cdk5 activation by p25 triggers pathological events leading to neuro-degeneration and neurofibrillary tangles. Neuron 40:471-483
23. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH 2000 Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364
24. Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S 2000 Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275:17166-17172
25. Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, Kim N, Rao S, Player A, Zheng YL, Garabedian MJ, Kawasaki E, Pant HC, Chrousos GP 2007 Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 21: 1552-1568
26. Kesavapany S, Li BS, Amin N, Zheng YL, Grant P, Pant HC 2004 Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide. Biochim Biophys Acta 1697:143-153
27. Franco PJ, Li G, Wei LN 2003 Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase. Mol Cell Endocrinol 206:1-12 (Pubitemid 37011248)
28. Liu W, Wang J, Sauter NK, Pearce D 1995 Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA 92:12480-12484
29. Ou XM, Storring JM, Kushwaha N, Albert PR 2001 Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J Biol Chem 276:14299-14307
30. Veeranna, Shetty KT, Link WT, Jaffe H, Wang J, Pant HC 1995 Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J Neurochem 64:2681-2690
31. Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, Brickey DA, Soderling TR, Bartleson C, Graves DJ, DeMaggio AJ, Hoekstra MF, Blenis J, Hunter T, Cantley LC 1996 A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol 16:6486-6493
32. Beaudette KN, Lew J, Wang JH 1993 Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain. J Biol Chem 268:20825-20830 (Pubitemid 23292256)
33. Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH 1998 p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem 273:24057-24064
34. Tan TC, Valova VA, Malladi CS, Graham ME, Berven LA, Jupp OJ, Hansra G, McClure SJ, Sarcevic B, Boadle RA, Larsen MR, Cousin MA, Robinson PJ 2003 Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 5:701-710
35. Taylor JR, Lynch WJ, Sanchez H, Olausson P, Nestler EJ, Bibb JA 2007 Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine. Proc Natl Acad Sci USA 104:4147-4152
36. Govindan MV, Warriar N 1998 Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J Biol Chem 273:24439-24447
37. Ernfors P, Bramham CR 2003 The coupling of a trkB tyrosine residue to LTP. Trends Neurosci 26:171-173
38. Nair A, Vaidya VA 2006 Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci 31:423-434
39. Shors TJ, Seib TB, Levine S, Thompson RF 1989 Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science 244:224-226
40. Diamond DM, Fleshner M, Rose GM 1994 Psychological stress repeatedly blocks hippocampal primed burst potentiation in behaving rats. Behav Brain Res 62:1-9
41. Sousa N, Almeida OF 2002 Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 13:59-84
42. Gass P, Kretz O, Wolfer DP, Berger S, Tronche F, Reichardt HM, Kellendonk C, Lipp HP, Schmid W, Schütz G 2000 Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep 1:447-451
43. Boyle MP, Kolber BJ, Vogt SK, Wozniak DF, Muglia LJ 2006 Forebrain glucocorticoid receptors modulate anxiety-associated locomotor activation and adrenal responsiveness. J Neurosci 26: 1971-1978
44. Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y, Muglia LJ 2005 Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci USA 102:473-478
45. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schütz G 1999 Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99-103
46. Gass P, Reichardt HM, Strekalova T, Henn F, Tronche F 2001 Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety? Physiol Behav 73:811-825
47. Lindvall O, Kokaia Z, Bengzon J, Elmér E, Kokaia M 1994 Neurotrophins and brain insults. Trends Neurosci 17:490-496
48. Korte M, Kang H, Bonhoeffer T, Schuman E 1998 A role for BDNF in the late-phase of hippocampal long-term potentiation. Neuropharmacology 37:553-559
49. Kang H, Schuman EM 1995 Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267:1658-1662
50. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T 1995 Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860
51. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65:1740-1751
52. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH 2009 Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15:331-337
53. Yulud B, Ozan E, Gönül AS, Kilic E 2009 Brain-derived neurotrophic factor, stress and depression: a minireview. Brain Res Bull 78:267-269
54. Schaaf MJ, Hoetelmans RW, de Kloet ER, Vreugdenhil E 1997 Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus. J Neurosci Res 48:334-341
55. Murer MG, Yan Q, Raisman-Vozari R 2001 Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63:71-124
56. Kino T, Slobodskaya O, Pavlakis GN, Chrousos GP 2002 Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem 277:2396-2405
57. Ichijo T, Voutetakis A, Cotrim AP, Bhattachryya N, Fujii M, Chrousos GP, Kino T 2005 The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J Biol Chem 280:42067-42077
58. Kino T, Tiulpakov A, Ichijo T, Chheng L, Kozasa T, Chrousos GP 2005 G protein β interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol 169:885-896
59. Nader N, Chrousos GP, Kino T 2009 Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J 23:1572-1583
60. Stone KL, Williams KR 1993 Enzymatic digestion of proteins and HPLC peptide isolation. In: Matsudaira PT, ed. A practical guide to protein and peptide purification for microsequencing. 2nd ed. San Diego, CA: Academic Press, Inc.; 43-69
61. Wu J, Shakey Q, Liu W, Schuller A, Follettie MT 2007 Global profiling of phosphopeptides by titania affinity enrichment. J Proteome Res 6:4684-4689